Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases
dc.authorid | Sarikaya, Ismet/0000-0002-1087-580X | |
dc.authorid | Schierz, Jan-Henning/0000-0002-6517-6029 | |
dc.authorwosid | Sarikaya, Ismet/G-7881-2015 | |
dc.authorwosid | Schierz, Jan-Henning/AAC-1692-2022 | |
dc.contributor.author | Sarikaya, Ismet | |
dc.contributor.author | Schierz, Jan-Henning | |
dc.contributor.author | Sarikaya, Ali | |
dc.date.accessioned | 2024-06-12T11:07:45Z | |
dc.date.available | 2024-06-12T11:07:45Z | |
dc.date.issued | 2021 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Liver has a complex and unique energy metabolism and plays a major role in glucose homeostasis. Liver is the main control center for glycogenesis, glycogenolysis, glycolysis and gluconeogenesis which are essential to provide energy for other tissues. Liver meets its own energy need from various sources which is mainly glucose in the fed state and fatty acids in the fasting state. In this review article, we will mainly describe the glucose metabolism of the liver, effect of various factors on 18F-fluorodeoxyglucose (FDG) activity/uptake in the normal liver and 18F-FDG positron emission tomography (PET) uptake patterns in various malignant and benign liver pathologies. Brief information on metabolomics profiling analyses in liver disorders will also be be provided. | en_US |
dc.identifier.endpage | 249 | en_US |
dc.identifier.issn | 2160-8407 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 34513277 | en_US |
dc.identifier.startpage | 233 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22175 | |
dc.identifier.volume | 11 | en_US |
dc.identifier.wos | WOS:000709287900001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | E-Century Publishing Corp | en_US |
dc.relation.ispartof | American Journal Of Nuclear Medicine And Molecular Imaging | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Liver | en_US |
dc.subject | Glucose Metabolism | en_US |
dc.subject | FDG PET | en_US |
dc.subject | Liver Lesions | en_US |
dc.subject | Nodular Hyperplasia Fnh | en_US |
dc.subject | Hepatocellular-Carcinoma | en_US |
dc.subject | Fdg-Uptake | en_US |
dc.subject | F-18-Fdg Pet | en_US |
dc.subject | Extrahepatic Metastases | en_US |
dc.subject | Hepatic Angiosarcoma | en_US |
dc.subject | Energy-Metabolism | en_US |
dc.subject | Blood-Flow | en_US |
dc.subject | In-Vivo | en_US |
dc.subject | Cancer | en_US |
dc.title | Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases | en_US |
dc.type | Review Article | en_US |